| Year |
Citation |
Score |
| 2023 |
van Andel DM, Sprengers JJ, Königs M, de Jonge MV, Bruining H. Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial. Journal of Autism and Developmental Disorders. PMID 36626004 DOI: 10.1007/s10803-022-05841-3 |
0.326 |
|
| 2022 |
Diachenko M, Houtman SJ, Juarez-Martinez EL, Ramautar JR, Weiler R, Mansvelder HD, Bruining H, Bloem P, Linkenkaer-Hansen K. Improved Manual Annotation of EEG Signals through Convolutional Neural Network Guidance. Eneuro. 9. PMID 36104277 DOI: 10.1523/ENEURO.0160-22.2022 |
0.691 |
|
| 2022 |
Juarez-Martinez EL, van Andel DM, Sprengers JJ, Avramiea AE, Oranje B, Scheepers FE, Jansen FE, Mansvelder HD, Linkenkaer-Hansen K, Bruining H. Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study. Frontiers in Neuroscience. 16: 879451. PMID 35645706 DOI: 10.3389/fnins.2022.879451 |
0.758 |
|
| 2022 |
van Andel DM, Sprengers JJ, Keijzer-Veen MG, Schulp AJA, Lillien MR, Scheepers FE, Bruining H. Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial. Frontiers in Psychiatry. 13: 780281. PMID 35211042 DOI: 10.3389/fpsyt.2022.780281 |
0.356 |
|
| 2022 |
Geertjens L, van Voorst TW, Bouman A, van Boven MA, Kleefstra T, Verhage M, Linkenkaer-Hansen K, Nadif Kasri N, Cornelisse LN, Bruining H. Following Excitation/Inhibition Ratio Homeostasis from Synapse to EEG in Monogenetic Neurodevelopmental Disorders. Genes. 13. PMID 35205434 DOI: 10.3390/genes13020390 |
0.677 |
|
| 2021 |
Houtman SJ, Lammertse HCA, van Berkel AA, Balagura G, Gardella E, Ramautar JR, Reale C, Møller RS, Zara F, Striano P, Misra-Isrie M, van Haelst MM, Engelen M, van Zuijen TL, Mansvelder HD, ... ... Bruining H, et al. Syndrome Is Characterized by Inhibition-Dominated Dynamics of Resting-State EEG. Frontiers in Physiology. 12: 775172. PMID 35002760 DOI: 10.3389/fphys.2021.775172 |
0.728 |
|
| 2021 |
Juarez-Martinez EL, Sprengers JJ, Cristian G, Oranje B, van Andel DM, Avramiea AE, Simpraga S, Houtman SJ, Hardstone R, Gerver C, Jan van der Wilt G, Mansvelder HD, Eijkemans MJC, Linkenkaer-Hansen K, Bruining H. Prediction of behavioral improvement through resting-state EEG and clinical severity in a randomized controlled trial testing bumetanide in autism spectrum disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34506972 DOI: 10.1016/j.bpsc.2021.08.009 |
0.72 |
|
| 2020 |
Bruining H, Hardstone R, Juarez-Martinez EL, Sprengers J, Avramiea AE, Simpraga S, Houtman SJ, Poil SS, Dallares E, Palva S, Oranje B, Matias Palva J, Mansvelder HD, Linkenkaer-Hansen K. Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics. Scientific Reports. 10: 9195. PMID 32513931 DOI: 10.1038/S41598-020-65500-4 |
0.737 |
|
| 2019 |
Juarez Martinez EL, Bruining H, Sprengers J, Simpraga S, Houtman S, Poil S, Mansvelder HD, Jansen F, Oranje B, Hardstone R, Linkenkaer-Hansen K. O-20 Epileptiform and non-epileptiform EEG abnormalities in Autism Spectrum Disorder relate to opposite excitation-inhibition balance disturbances Clinical Neurophysiology. 130: e27-e28. DOI: 10.1016/J.Clinph.2019.04.336 |
0.739 |
|
| 2019 |
Marije van Andel D, Sprengers J, Juarez-Martinez E, Simpraga S, Oranje B, Linkenkaer-Hansen K, de Jonge M, Bruining H. 222. Cognitive Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S92. DOI: 10.1016/J.Biopsych.2019.03.236 |
0.573 |
|
| 2019 |
Sprengers J, Oranje B, Marije van Andel D, Juarez-Martinez E, Simpraga S, Linkenkaer-Hansen K, Bruining H. 221. Behavioural and Neurophysiological Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) Trial Biological Psychiatry. 85: S91-S92. DOI: 10.1016/J.Biopsych.2019.03.235 |
0.591 |
|
| 2019 |
Bruining H, Juarez-Martinez E, Sprengers J, Marije van Andel D, Simpraga S, Poil S, Dellares E, Mansvelder H, Oranje B, Hardstone R, Linkenkaer-Hansen K. 220. Non-Invasive Estimation of Excitation-Inhibition Balance Facilitates Physiological Dissection of Autism Spectrum Disorder Biological Psychiatry. 85: S91. DOI: 10.1016/J.Biopsych.2019.03.234 |
0.715 |
|
| 2017 |
Vlaskamp C, Poil SS, Jansen F, Linkenkaer-Hansen K, Durston S, Oranje B, Bruining H. Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex. Frontiers in Neurology. 8: 469. PMID 28943860 DOI: 10.3389/Fneur.2017.00469 |
0.573 |
|
| 2017 |
Srengers J, Martinez EJ, Simpraga S, Jansen F, Vlaskamp C, Oranje B, Poil S, Linkenkaer-Hansen K, Bruining H. O132 An EEG-based decision-support system for diagnosis and prognosis of autism spectrum disorder Clinical Neurophysiology. 128: e221. DOI: 10.1016/J.Clinph.2017.07.143 |
0.732 |
|
| 2015 |
van Campen JS, Jansen FE, Kleinrensink NJ, Joëls M, Braun KP, Bruining H. Sensory modulation disorders in childhood epilepsy. Journal of Neurodevelopmental Disorders. 7: 34. PMID 26504494 DOI: 10.1186/s11689-015-9130-9 |
0.351 |
|
| 2015 |
Bruining H, Passtoors L, Goriounova N, Jansen F, Hakvoort B, de Jonge M, Poil SS. Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders? Pediatrics. 136: e539-43. PMID 26216321 DOI: 10.1542/peds.2014-4133 |
0.311 |
|
| 2015 |
van Diessen E, Senders J, Jansen FE, Boersma M, Bruining H. Increased power of resting-state gamma oscillations in autism spectrum disorder detected by routine electroencephalography. European Archives of Psychiatry and Clinical Neuroscience. 265: 537-40. PMID 25182536 DOI: 10.1007/s00406-014-0527-3 |
0.396 |
|
| 2010 |
Bruining H, de Sonneville L, Swaab H, de Jonge M, Kas M, van Engeland H, Vorstman J. Dissecting the clinical heterogeneity of autism spectrum disorders through defined genotypes. Plos One. 5: e10887. PMID 20526357 DOI: 10.1371/journal.pone.0010887 |
0.321 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Xian J, Parthasarathy S, Ruggiero SM, Balagura G, Fitch E, Helbig K, Gan J, Ganesan S, Kaufman MC, Ellis CA, Lewis-Smith D, Galer P, Cunningham K, O'Brien M, Cosico M, ... ... Bruining H, et al. Assessing the landscape of STXBP1-related disorders in 534 individuals. Brain : a Journal of Neurology. PMID 35190816 DOI: 10.1093/brain/awab327 |
0.289 |
|
| 2020 |
van Andel DM, Sprengers JJ, Oranje B, Scheepers FE, Jansen FE, Bruining H. Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study. Molecular Autism. 11: 30. PMID 32381101 DOI: 10.1186/s13229-020-00335-4 |
0.28 |
|
| 2014 |
Bruining H, Eijkemans MJ, Kas MJ, Curran SR, Vorstman JA, Bolton PF. Behavioral signatures related to genetic disorders in autism. Molecular Autism. 5: 11. PMID 24517317 DOI: 10.1186/2040-2392-5-11 |
0.278 |
|
| 2021 |
van Andel DM, van Stel HF, Scheepers FE, Oostrom KJ, Haverman L, Bruining H. The sensory-reactivity PROM set: identification of a parent reported outcome measure set for autism spectrum disorder. Journal of Patient-Reported Outcomes. 5: 123. PMID 34787751 DOI: 10.1186/s41687-021-00396-w |
0.271 |
|
| 2016 |
Molenhuis RT, Bruining H, Remmelink E, de Visser L, Loos M, Burbach JP, Kas MJ. Limited impact of Cntn4 mutation on autism-related traits in developing and adult C57BL/6J mice. Journal of Neurodevelopmental Disorders. 8: 6. PMID 26958094 DOI: 10.1186/s11689-016-9140-2 |
0.269 |
|
| 2020 |
Sprengers JJ, van Andel DM, Zuithoff NP, Keijzer-Veen MG, Schulp AJ, Scheepers FE, Lilien MR, Oranje B, Bruining H. Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 32730977 DOI: 10.1016/j.jaac.2020.07.888 |
0.264 |
|
| 2022 |
van Eeghen AM, Bruining H, Wolf NI, Bergen AA, Houtkooper RH, van Haelst MM, van Karnebeek CD. Personalized medicine for rare neurogenetic disorders: can we make it happen? Cold Spring Harbor Molecular Case Studies. 8. PMID 35332073 DOI: 10.1101/mcs.a006200 |
0.259 |
|
| 2022 |
Kooper CC, Oosterlaan J, Bruining H, Engelen M, Pouwels PJW, Popma A, van Woensel JBM, Buis DR, Steenweg ME, Hunfeld M, Königs M. Towards PErsonalised PRognosis for children with traumatic brain injury: the PEPR study protocol. Bmj Open. 12: e058975. PMID 35768114 DOI: 10.1136/bmjopen-2021-058975 |
0.259 |
|
| 2022 |
Botchway E, Kooper CC, Pouwels PJW, Bruining H, Engelen M, Oosterlaan J, Königs M. Resting-state network organisation in children with traumatic brain injury. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 154: 89-104. PMID 35763900 DOI: 10.1016/j.cortex.2022.05.014 |
0.258 |
|
| 2022 |
Geertjens L, Cristian G, Haspels E, Ramautar J, van der Wilt GJ, Verhage M, Bruining H. Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol. Bmc Psychiatry. 22: 452. PMID 35799144 DOI: 10.1186/s12888-022-04033-8 |
0.258 |
|
| 2012 |
van Rijn S, Bierman M, Bruining H, Swaab H. Vulnerability for autism traits in boys and men with an extra X chromosome (47,XXY): the mediating role of cognitive flexibility. Journal of Psychiatric Research. 46: 1300-6. PMID 22884425 DOI: 10.1016/j.jpsychires.2012.06.004 |
0.25 |
|
| 2023 |
den Hollander B, Rothuizen-Lindenschot M, Geertjens L, Vaz FM, Brands MM, Le HL, van Eeghen AM, van de Ven PM, Cornel MC, Jacobs BAW, Bruining H, van Karnebeek CD. Effectiveness of L-serine supplementation in children with a loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials. Contemporary Clinical Trials Communications. 36: 101233. PMID 38144875 DOI: 10.1016/j.conctc.2023.101233 |
0.228 |
|
| 2023 |
Bozhilova N, Welham A, Adams D, Bissell S, Bruining H, Crawford H, Eden K, Nelson L, Oliver C, Powis L, Richards C, Waite J, Watson P, Rhys H, Wilde L, et al. Profiles of autism characteristics in thirteen genetic syndromes: a machine learning approach. Molecular Autism. 14: 3. PMID 36639821 DOI: 10.1186/s13229-022-00530-5 |
0.216 |
|
| 2018 |
Molenhuis RT, Bruining H, Brandt MJV, van Soldt PE, Abu-Toamih Atamni HJ, Burbach JPH, Iraqi FA, Mott RF, Kas MJH. Modeling the quantitative nature of neurodevelopmental disorders using Collaborative Cross mice. Molecular Autism. 9: 63. PMID 30559955 DOI: 10.1186/s13229-018-0252-2 |
0.211 |
|
| 2014 |
van Elst K, Bruining H, Birtoli B, Terreaux C, Buitelaar JK, Kas MJ. Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neuroscience and Biobehavioral Reviews. 45: 369-78. PMID 25025657 DOI: 10.1016/J.Neubiorev.2014.07.004 |
0.211 |
|
| 2014 |
van Rijn S, Stockmann L, Borghgraef M, Bruining H, van Ravenswaaij-Arts C, Govaerts L, Hansson K, Swaab H. The social behavioral phenotype in boys and girls with an extra X chromosome (Klinefelter syndrome and Trisomy X): a comparison with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 310-20. PMID 23824705 DOI: 10.1007/s10803-013-1860-5 |
0.211 |
|
| 2018 |
Schulte JT, Wierenga CJ, Bruining H. Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions. Neuroscience and Biobehavioral Reviews. 90: 260-271. PMID 29729285 DOI: 10.1016/j.neubiorev.2018.05.001 |
0.207 |
|
| 2009 |
Bruining H, Swaab H, Kas M, van Engeland H. Psychiatric characteristics in a self-selected sample of boys with Klinefelter syndrome. Pediatrics. 123: e865-70. PMID 19364768 DOI: 10.1542/peds.2008-1954 |
0.2 |
|
| 2012 |
Laarakker MC, Reinders NR, Bruining H, Ophoff RA, Kas MJH. Sex-dependent novelty response in neurexin-1α mutant mice Plos One. 7. PMID 22348092 DOI: 10.1371/journal.pone.0031503 |
0.192 |
|
| 2011 |
Bruining H, Swaab H, de Sonneville LM, van Rijn S, van Engeland H, Kas MJ. In search for significant cognitive features in Klinefelter syndrome through cross-species comparison of a supernumerary X chromosome. Genes, Brain, and Behavior. 10: 658-62. PMID 21605339 DOI: 10.1111/j.1601-183X.2011.00705.x |
0.186 |
|
| 2014 |
Molenhuis RT, de Visser L, Bruining H, Kas MJ. Enhancing the value of psychiatric mouse models; differential expression of developmental behavioral and cognitive profiles in four inbred strains of mice European Neuropsychopharmacology. 24: 945-954. PMID 24491952 DOI: 10.1016/j.euroneuro.2014.01.013 |
0.179 |
|
| 2017 |
Molenhuis RT, Bruining H, Kas MJ. Modelling Autistic Features in Mice Using Quantitative Genetic Approaches. Advances in Anatomy, Embryology, and Cell Biology. 224: 65-84. PMID 28551751 DOI: 10.1007/978-3-319-52498-6_4 |
0.175 |
|
| 2017 |
van Tuijl DC, Groenwold RHH, Vlaskamp C, van Campen JS, Braun KPJ, Jansen FE, Bruining H. Behavioral disinhibition and antiepileptic treatment in childhood epilepsy: A retrospective cohort study. Epilepsia Open. 2: 59-66. PMID 29750213 DOI: 10.1002/epi4.12032 |
0.159 |
|
| 2015 |
Bruining H, Matsui A, Oguro-Ando A, Kahn RS, Van't Spijker HM, Akkermans G, Stiedl O, van Engeland H, Koopmans B, van Lith HA, Oppelaar H, Tieland L, Nonkes LJ, Yagi T, Kaneko R, et al. Genetic Mapping in Mice Reveals the Involvement of Pcdh9 in Long-Term Social and Object Recognition and Sensorimotor Development. Biological Psychiatry. PMID 25802080 DOI: 10.1016/J.Biopsych.2015.01.017 |
0.159 |
|
| 2024 |
Sprengers JJ, Geertjens L, Bruining H. Mechanism-based interventions for ASD cannot be implemented using conventional trial designs. Autism Research : Official Journal of the International Society For Autism Research. PMID 38197172 DOI: 10.1002/aur.3086 |
0.15 |
|
| 2022 |
Fischer K, Tieskens JM, Luijten MAJ, Zijlmans J, van Oers HA, de Groot R, van der Doelen D, van Ewijk H, Klip H, van der Lans RM, De Meyer R, van der Mheen M, van Muilekom MM, Hyun Ruisch I, Teela L, ... ... Bruining H, et al. Internalizing problems before and during the COVID-19 pandemic in independent samples of Dutch children and adolescents with and without pre-existing mental health problems. European Child & Adolescent Psychiatry. PMID 35616715 DOI: 10.1007/s00787-022-01991-y |
0.137 |
|
| 2017 |
Scott R, Sánchez-Aguilera A, van Elst K, Lim L, Dehorter N, Bae SE, Bartolini G, Peles E, Kas MJH, Bruining H, Marín O. Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior. Cerebral Cortex (New York, N.Y. : 1991). PMID 29300891 DOI: 10.1093/Cercor/Bhx341 |
0.129 |
|
| 2024 |
Hollander BD, Rothuizen-Lindenschot M, Geertjens L, Vaz FM, Brands MM, Le HL, van Eeghen AM, van de Ven PM, Cornel MC, Jacobs BAW, Bruining H, van Karnebeek CD. Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233]. Contemporary Clinical Trials Communications. 38: 101264. PMID 38533474 DOI: 10.1016/j.conctc.2024.101264 |
0.12 |
|
| 2018 |
Schieveld JNM, Strik JJMH, Bruining H. On Benzodiazepines, Paradoxical Agitation, Hyperactive Delirium, and Chloride Homeostasis. Critical Care Medicine. 46: 1558-1559. PMID 30113377 DOI: 10.1097/CCM.0000000000003231 |
0.119 |
|
| 2021 |
Kat R, Berg BVD, Perenboom MJ, Schenke M, Maagdenberg AMVD, Bruining H, Tolner EA, Kas MJ. EEG-based visual deviance detection in freely behaving mice. Neuroimage. 245: 118757. PMID 34838751 DOI: 10.1016/j.neuroimage.2021.118757 |
0.105 |
|
| 2019 |
Greven CU, Lionetti F, Booth C, Aron E, Fox E, Schendan HE, Pluess M, Bruining H, Acevedo B, Bijttebier P, Homberg J. Sensory Processing Sensitivity in the context of Environmental Sensitivity: a critical review and development of research agenda. Neuroscience and Biobehavioral Reviews. PMID 30639671 DOI: 10.1016/j.neubiorev.2019.01.009 |
0.1 |
|
| 1995 |
Arnold J, Hendriks J, Ince C, Bruining H. Tonometry to assess the adequacy of splanchnic oxygenation in the critically ill patient. Intensive Care Medicine. 20: 452-6. PMID 7798454 DOI: 10.1007/BF01710660 |
0.094 |
|
| 2010 |
Bruining H, van Rijn S, Swaab H, Giltay J, Kates W, Kas MJ, van Engeland H, de Sonneville L. The parent-of-origin of the extra X chromosome may differentially affect psychopathology in Klinefelter syndrome. Biological Psychiatry. 68: 1156-62. PMID 21035791 DOI: 10.1016/j.biopsych.2010.08.034 |
0.088 |
|
| 2011 |
Laarakker M, Reinders N, Bruining H, Ophoff R, Kas M. P.4.007 Human schizophrenia and autism candidate gene neurexin1a regulates behavioural habituation in mice European Neuropsychopharmacology. 21: S83-S84. DOI: 10.1016/S0924-977X(11)70096-7 |
0.088 |
|
| 2012 |
Wierda E, Reesink HJ, Bruining H, van Delden OM, Kloek JJ, Bresser P. Successful pulmonary endarterectomy in a patient with klinefelter syndrome. Case Reports in Pulmonology. 2012: 104195. PMID 23304604 DOI: 10.1155/2012/104195 |
0.078 |
|
| 2023 |
Zijlmans J, Tieskens JM, van Oers HA, Alrouh H, Luijten MAJ, de Groot R, van der Doelen D, Klip H, van der Lans RM, de Meyer R, van der Mheen M, Ruisch IH, van den Berg G, Bruining H, Buitelaar J, et al. The effects of COVID-19 on child mental health: Biannual assessments up to April 2022 in a clinical and two general population samples. Jcpp Advances. 3: e12150. PMID 37753155 DOI: 10.1002/jcv2.12150 |
0.065 |
|
| 1998 |
Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nyström PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Medicine. 24: 206-16. PMID 9565801 DOI: 10.1007/s001340050552 |
0.049 |
|
| 2008 |
Bruining H, van Engeland H, Oppelaar H, Petri E, Kas M. P.2.11 Gene function in social and non-social memory European Neuropsychopharmacology. 18: s45-s46. DOI: 10.1016/S0924-977X(08)70052-X |
0.04 |
|
| 2008 |
Bruining H, Tieland L, Swaab H, van Engeland H, Oppelaar H, Petri E, Kas M. S.07.02 Gene function in social and non-social memory European Neuropsychopharmacology. 18: S167. DOI: 10.1016/S0924-977X(08)70146-9 |
0.035 |
|
| 2014 |
Molenhuis R, Oguro-Ando A, Burbach J, Bruining H, Kas M. P.2.020 Deletion of contactin-4 leads to cognitive rigidity and aberrant motor cortex development in mice European Neuropsychopharmacology. 24: S47. DOI: 10.1016/S0924-977X(14)70053-7 |
0.031 |
|
| 2014 |
Molenhuis R, Oguro-Ando A, Burbach J, Bruining H, Kas M. S.12.04 Deletion of contactin-4 leads to cognitive rigidity and aberrant cortex development in mice European Neuropsychopharmacology. 24: S127. DOI: 10.1016/S0924-977X(14)70163-4 |
0.03 |
|
| 2020 |
Bruining H, Bartels M, Polderman TJC, Popma A. COVID-19 and child and adolescent psychiatry: an unexpected blessing for part of our population? European Child & Adolescent Psychiatry. PMID 32623697 DOI: 10.1007/s00787-020-01578-5 |
0.025 |
|
| 2017 |
Bruining H, van der Gaag RJ. Het brein in ontwikkeling: naar een rationele kinderpsychiatrie Bijblijven. 33: 638-644. DOI: 10.1007/s12414-017-0265-3 |
0.012 |
|
| 2021 |
Sprengers JJ, van Andel DM, Bruining H. Dr. Sprengers et al. Reply. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 33450401 DOI: 10.1016/j.jaac.2020.12.034 |
0.01 |
|
| Hide low-probability matches. |